F · Healthcare

NANOVIRICIDES NEW DL-01 (NV3P)

Biotechnology

NANOVIRICIDES NEW DL-01 (NV3P) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-30, reported market cap is $17.27M, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for NV3P

Market cap
$17.27M
P/E ratio
18.00
Gross profit (TTM)
$0
Net margin
0.0%

NANOVIRICIDES NEW DL-01 (NV3P) — FAQ

What is NANOVIRICIDES NEW DL-01's market cap?

NANOVIRICIDES NEW DL-01 (NV3P) has a reported market cap of $17.27M (data as of 2026-03-30).

What is NV3P's P/E ratio?

The price-to-earnings (P/E) ratio for NANOVIRICIDES NEW DL-01 (NV3P) is 18.00 (data as of 2026-03-30).

Does NANOVIRICIDES NEW DL-01 pay a dividend?

Dividend yield is not available in the current snapshot for NANOVIRICIDES NEW DL-01 (NV3P). Check the MyAverix Finance app for the latest dividend data.

What sector is NANOVIRICIDES NEW DL-01 in?

NANOVIRICIDES NEW DL-01 (NV3P) is classified in the Healthcare sector (Biotechnology industry).

What exchange is NV3P listed on?

NV3P is listed on F.

What is NANOVIRICIDES NEW DL-01's net margin?

NANOVIRICIDES NEW DL-01 (NV3P) reports a net margin of 0.0% (data as of 2026-03-30).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

App Store Google Play